Last update 19 Mar 2026

Levalbuterol hydrochloride/Ipratropium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2022HY052, BIOS 2302, BIOS-2302
+ [1]
Target
mAChRs x β2-adrenergic receptor
Action
antagonists, agonists
Mechanism
mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Respiratory Diseases
Active Indication-
Inactive Indication
Bronchial Spasm
Originator Organization
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
Active Organization-
Inactive Organization
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
License Organization
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.Beijing Yuanfang Tongda Pharmaceutical Technology Co., Ltd.Beijing Yuanfang Tongda Pharmaceutical Technology Co., Ltd.
Drug Highest PhasePendingClinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H22ClNO3
InChIKeyOWNWYCOLFIFTLK-YDALLXLXSA-N
CAS Registry50293-90-8

Related

1
Clinical Trials associated with Levalbuterol hydrochloride/Ipratropium
CTR20240783
/ CompletedNot Applicable
BIOS2302随机、开放、两制剂、交叉设计在中国健康受试者中的生物等效性试验
[Translation] BIOS2302: A randomized, open-label, two-drug, crossover bioequivalence trial in Chinese healthy subjects
100 Clinical Results associated with Levalbuterol hydrochloride/Ipratropium
Login to view more data
100 Translational Medicine associated with Levalbuterol hydrochloride/Ipratropium
Login to view more data
100 Patents (Medical) associated with Levalbuterol hydrochloride/Ipratropium
Login to view more data
100 Deals associated with Levalbuterol hydrochloride/Ipratropium
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bronchial SpasmClinical
China
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
10 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free